Recent Publications

Switch to: List view

The following papers have been supported by the CEED3 project:

Lead Author Other Authors Publication Title Date Publishedsort icon Journal Volume Pages
Gaal Z Klupa T, Kantor I, Mlynarski W, Albert L, Tolloczko J, Balogh I, Czajkowski K, Malecki MT. Sulfonylurea use during entire pregnancy in diabetes because of KCNJ11 mutation: a report of two cases June 2012 Diabetes Care Jun 2012;35(6) e40
Manning AK Hivert MF et al A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance May 2012 Nature Genetics May 13;44(6) 659-69
Fagerholm E Ahlqvist E, Forsblom C, Sandholm N, Syreeni A, Parkkonen M, McKnight AJ, Tarnow L, Maxwell AP, Parving HH, Groop L, Groop PH; FinnDiane Study Group. SNP in the genome-wode association study hotspot on chromosome 9p21 coners susceptibility to diabetic nephropathy in type 1 diabetes May 2012 Diabetologia Sep 2012;55(9) 2386-93
Ehret GB Munroe PB, Rice KM, Bochud M, Johnson AD, et al Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk May 2012 Nature Sep 11 2012;478(7367) 103-9
Stützer I, Esterházy D, Stoffel M The pancreatic beta cell surface proteome March 2012 Diabetologia Jul;55(7) 1877-89
Thanabalasingham G Pal A, Selwood MP, Dudley C, Fisher K, et al Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying Maturity-onset diabetes of the young March 2012 Diabetes Care Jun;35(6) 1206-12
Schwarz PE Greaves CJ, Lindstrom J, Yates T, Davies MJ et al No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels. March 2012 Diabetes May;61(5) 1291-6
Saha S Graessler J, Schwarz PE, Goettsch C, Bornstein SR, Kopprasch S Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways March 2012 Molecular and Cellular Biochemistry Jul;366(1-2)
Nowak N Szopa M, Thanabalasingham G, McDonald TJ, Colclough K, Skupien J, James TJ, Kiec-Wilk B, Kozek E, Mlynarski W, Hattersley AT, Owen KR, Malecki MT. Cystatin C is not a good candidate biomarker for HNF1A-MODY February 2012 Acta Diabetologica Feb-19 Epub ahead of print
Cnop M High fat feeding exacerbates endoplasmic reticulum stress and beta cell demise February 2012 European Journal of Lipid Science and Technology Feb 2012 114 229-232
McDonald TJ McEneny J, Pearson ER, Thanabalasingham G, Szopa M, Shields BM, Ellard S, Owen KR, Malecki MT, Hattersley AT, Young IS. Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes February 2012 Clinical Chemistry May 18;413(9-10) 927-32
Esterházy D Akpinar P, Stoffel M Tmem27 dimerisation, deglycosylation, plasma membrane depletion, and the extracellular Phe-Phe motif are negative regulators of cleavage by Bace2 February 2012 Biological Chemistry May 2012;393(6) 473-84
Zoldoš V Horvat T, Novokmet M, Cuenin C, Mužinić A, Pučić M, Huffman JE, Gornik O, Polašek O, Campbell H, Hayward C, Wright AF, Rudan I, Owen K, McCarthy MI, Herceg Z, Lauc G. Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome February 2012 Epigenetics Feb;7(2) 164-72
Volkmar M. Dedeurwaerder S, Cunha DA, Ndlovu MN, Defrance M, Deplus R, Calonne E, Volkmar U, Igoillo-Esteve M, Naamane N, Del Guerra S, Masini M, Bugliani M, Marchetti P, Cnop M, Eizirik DL, Fuks F. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients January 2012 Embo Journal Jan 31;31(6) 1405-26
Mäkinen VP, Tynkkynen T, Soininen P, Peltola T, Kangas AJ, Forsblom C, Thorn LM, Kaski K, Laatikainen R, Ala-Korpela M, Groop PH. Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes January 2012 Journal of Proteome Research Mar 2;11(3) 1782-90